vs

Side-by-side financial comparison of KAMADA LTD (KMDA) and OneSpan Inc. (OSPN). Click either name above to swap in a different company.

OneSpan Inc. is the larger business by last-quarter revenue ($65.9M vs $47.0M, roughly 1.4× KAMADA LTD). OneSpan Inc. runs the higher net margin — 17.5% vs 11.3%, a 6.3% gap on every dollar of revenue. On growth, KAMADA LTD posted the faster year-over-year revenue change (12.6% vs 4.1%). Over the past eight quarters, KAMADA LTD's revenue compounded faster (12.0% CAGR vs 4.0%).

Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma.

OneSpan Inc. is an information security company based in Boston, Massachusetts. Services include an internet fraud prevention platform, multi-factor authentication tools and electronic signature software.

KMDA vs OSPN — Head-to-Head

Bigger by revenue
OSPN
OSPN
1.4× larger
OSPN
$65.9M
$47.0M
KMDA
Growing faster (revenue YoY)
KMDA
KMDA
+8.6% gap
KMDA
12.6%
4.1%
OSPN
Higher net margin
OSPN
OSPN
6.3% more per $
OSPN
17.5%
11.3%
KMDA
Faster 2-yr revenue CAGR
KMDA
KMDA
Annualised
KMDA
12.0%
4.0%
OSPN

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
KMDA
KMDA
OSPN
OSPN
Revenue
$47.0M
$65.9M
Net Profit
$5.3M
$11.6M
Gross Margin
42.0%
73.6%
Operating Margin
16.6%
22.5%
Net Margin
11.3%
17.5%
Revenue YoY
12.6%
4.1%
Net Profit YoY
37.1%
EPS (diluted)
$0.09
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KMDA
KMDA
OSPN
OSPN
Q1 26
$65.9M
Q4 25
$62.9M
Q3 25
$47.0M
$57.1M
Q2 25
$44.8M
$59.8M
Q1 25
$44.0M
$63.4M
Q4 24
$61.2M
Q3 24
$41.7M
$56.2M
Q2 24
$42.5M
$60.9M
Net Profit
KMDA
KMDA
OSPN
OSPN
Q1 26
$11.6M
Q4 25
$43.5M
Q3 25
$5.3M
$6.5M
Q2 25
$7.4M
$8.3M
Q1 25
$4.0M
$14.5M
Q4 24
$28.8M
Q3 24
$3.9M
$8.3M
Q2 24
$4.4M
$6.6M
Gross Margin
KMDA
KMDA
OSPN
OSPN
Q1 26
73.6%
Q4 25
73.6%
Q3 25
42.0%
73.6%
Q2 25
42.3%
73.5%
Q1 25
47.1%
74.3%
Q4 24
74.0%
Q3 24
41.3%
73.9%
Q2 24
44.6%
66.2%
Operating Margin
KMDA
KMDA
OSPN
OSPN
Q1 26
22.5%
Q4 25
19.9%
Q3 25
16.6%
14.4%
Q2 25
15.8%
17.6%
Q1 25
17.7%
27.1%
Q4 24
19.3%
Q3 24
12.7%
20.0%
Q2 24
13.3%
12.5%
Net Margin
KMDA
KMDA
OSPN
OSPN
Q1 26
17.5%
Q4 25
69.2%
Q3 25
11.3%
11.4%
Q2 25
16.5%
13.9%
Q1 25
9.0%
22.9%
Q4 24
47.1%
Q3 24
9.3%
14.7%
Q2 24
10.4%
10.8%
EPS (diluted)
KMDA
KMDA
OSPN
OSPN
Q1 26
$0.39
Q4 25
$1.13
Q3 25
$0.09
$0.17
Q2 25
$0.13
$0.21
Q1 25
$0.07
$0.37
Q4 24
$0.73
Q3 24
$0.07
$0.21
Q2 24
$0.08
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KMDA
KMDA
OSPN
OSPN
Cash + ST InvestmentsLiquidity on hand
$72.0M
$49.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$265.2M
$272.0M
Total Assets
$377.2M
$383.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KMDA
KMDA
OSPN
OSPN
Q1 26
$49.8M
Q4 25
$70.5M
Q3 25
$72.0M
$85.6M
Q2 25
$66.0M
$92.9M
Q1 25
$76.3M
$105.2M
Q4 24
$83.2M
Q3 24
$72.0M
$77.5M
Q2 24
$56.5M
$63.8M
Stockholders' Equity
KMDA
KMDA
OSPN
OSPN
Q1 26
$272.0M
Q4 25
$271.8M
Q3 25
$265.2M
$238.3M
Q2 25
$260.0M
$242.5M
Q1 25
$252.0M
$231.1M
Q4 24
$212.5M
Q3 24
$255.3M
$194.6M
Q2 24
$251.2M
$178.6M
Total Assets
KMDA
KMDA
OSPN
OSPN
Q1 26
$383.1M
Q4 25
$397.7M
Q3 25
$377.2M
$343.5M
Q2 25
$368.2M
$357.1M
Q1 25
$375.1M
$333.8M
Q4 24
$338.7M
Q3 24
$351.2M
$289.3M
Q2 24
$351.0M
$286.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KMDA
KMDA
OSPN
OSPN
Operating Cash FlowLast quarter
$10.4M
$28.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.97×
2.44×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KMDA
KMDA
OSPN
OSPN
Q1 26
$28.2M
Q4 25
$12.6M
Q3 25
$10.4M
$11.3M
Q2 25
$8.0M
$6.2M
Q1 25
$-513.0K
$29.4M
Q4 24
$12.4M
Q3 24
$22.2M
$14.0M
Q2 24
$14.0M
$2.3M
Free Cash Flow
KMDA
KMDA
OSPN
OSPN
Q1 26
Q4 25
$9.6M
Q3 25
$8.8M
Q2 25
$4.4M
Q1 25
$27.7M
Q4 24
$10.5M
Q3 24
$12.0M
Q2 24
$26.0K
FCF Margin
KMDA
KMDA
OSPN
OSPN
Q1 26
Q4 25
15.3%
Q3 25
15.4%
Q2 25
7.3%
Q1 25
43.8%
Q4 24
17.1%
Q3 24
21.4%
Q2 24
0.0%
Capex Intensity
KMDA
KMDA
OSPN
OSPN
Q1 26
Q4 25
4.7%
Q3 25
4.4%
Q2 25
3.1%
Q1 25
2.6%
Q4 24
3.2%
Q3 24
3.5%
Q2 24
3.7%
Cash Conversion
KMDA
KMDA
OSPN
OSPN
Q1 26
2.44×
Q4 25
0.29×
Q3 25
1.97×
1.74×
Q2 25
1.09×
0.75×
Q1 25
-0.13×
2.02×
Q4 24
0.43×
Q3 24
5.75×
1.69×
Q2 24
3.15×
0.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KMDA
KMDA

Segment breakdown not available.

OSPN
OSPN

Product and license$35.5M54%
Services and other$30.4M46%

Related Comparisons